Cabozantinib in Hepatocellular Carcinoma

N Engl J Med. 2018 Oct 4;379(14):1384. doi: 10.1056/NEJMc1810178.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Anilides
  • Antineoplastic Agents
  • Carcinoma, Hepatocellular*
  • Humans
  • Liver Neoplasms*
  • Protein Kinase Inhibitors
  • Pyridines

Substances

  • Anilides
  • Antineoplastic Agents
  • Protein Kinase Inhibitors
  • Pyridines
  • cabozantinib